To identify growth opportunities in the chemotherapy treatment market, the market has been segmented into regions that are growing faster than the overall market. These regions have been pitted against regions that have a slower growth rate than the global market in 2019-2023. Europe and North America will grow faster than the overall market. Asia and ROW’s growth will be slower than the global market.

Some of the key findings from our chemotherapy treatment market forecast report are summarized below

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the chemotherapy treatment market report.

Get a FREE sample now!

Global chemotherapy treatment industry overview

Chemotherapy drugs cause several side effects such as peripheral neuropathy, vomiting and nausea, hypersensitivity reactions, neutropenia, and gastrointestinal side effects. This has led to the development of several drugs to counter these side-effects. Antiemetics such as palonosetron, dolasetron, granisetron, and tropisetron are used to treat chemotherapy-induced vomiting and nausea. Similarly, colony-stimulating factor (agents) such as filgrastim and pegfilgrastim are used to treat neutropenia and stimulate the production of neutrophils from the bone marrow. The availability of such drugs to treat chemotherapy-induced side effects is expected to drive the growth of the chemotherapy treatment market during the forecast period.

The increase in drug resistance has led to the development of combination therapies. Combination therapy has the potential to reduce drug resistance as tumors are expected to have less resistance to multiple drugs. Many vendors are developing combination therapies with chemotherapy drugs besides targeted therapies. Most of the combination therapy drugs are currently in Phase III of clinical trials and is expected to receive marketing approval over the forecast period. The development of combination therapies is one of the key trends that will fuel the growth of the chemotherapy treatment market at a CAGR of nearly 3% during the forecast period.

Top companies covered in the chemotherapy treatment market research report

The global chemotherapy treatment market is fairly concentrated. To help clients improve their revenue share, the chemotherapy market research report provides an analysis of the market's competitive landscape and offers information on the products offered by various leading companies. Key insights provided in the chemotherapy market analysis report will help companies make informed business decisions.

The report offers a detailed analysis of several leading companies, including:

• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• Johnson & Johnson Services Inc.
• Novartis AG
• Pfizer Inc.

Chemotherapy treatment market segmentation based on drug class

• Antimetabolites
• Plant derivatives
• Cytotoxic antibiotics
• Alkylating agents
• Others

The antimetabolites segment will account for the largest global chemotherapy treatment market share during the forecast period. Antimetabolite such as methotrexate are commonly used as a chemotherapeutic agent to treat patients with breast, colon, bladder, and head and cancers. Similarly, gemcitabine is an antimetabolite that is found to be active against solid tumors and is less expected to cause myelosuppression. Such chemotherapeutic properties offered by antimetabolites is driving the growth of the chemotherapy treatment market in this segment.

Chemotherapy treatment market segmentation based on geography

• Asia
• Europe
• North America
• ROW

North America is the largest geographical segment of the global chemotherapy treatment market. The chemotherapy market in North America is driven by the growing prevalence of cancer in the US. The strong presence of global vendors in the region and the availability of chemotherapeutics is contributing to the growth of the market. Also, the approval of combination therapies that are in the late stages of clinical trials is expected to drive the chemotherapy treatment market in North America.

Key highlights of the global chemotherapy treatment market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the chemotherapy market during the next five years
• Precise estimation of the global chemotherapy treatment market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the chemotherapy treatment industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market's competitive landscape and detailed information on several vendors
• Comprehensive details of factors that will challenge the growth of chemotherapy treatment companies  

We can help! Our analysts can customize the chemotherapy treatment market market research report to meet your requirements. Get in touch